Related Experiment Video
Updated: Jun 27, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Occult prostate cancer effects the results of case-control studies due to verification bias
Taro Iguchi1, Ching Y Wang, Nicolas B Delongchamps
1Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
Background:
Epidemiological studies of prostate cancer (PCA) which are based on case control comparisons may be effected by verification bias. Verification bias exists when the experimental group has verified PCA, while the control group is presumed to be cancer free, but this is not histologically verified.
Materials And Methods:
Review of the literature and our recent experience with case-control studies of PCA in an autopsy model.
Results:
When autopsied prostates were evaluated for cancer based on prostatic specific antigen <4 ng/ml, negative biopsy or both criteria, the contamination rate was 22%, 15% or 12%, respectively. The effect of contamination by occult PCA alters the odds ratio and p-value of the results.
Conclusion:
It is important to recognize that contamination of the control population by occult carcinomas reduces the reliability of the results. Rigorous characterization of the experimental and control groups is needed in order to preserve the integrity of the conclusions.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Confounding in Epidemiological Studies
Bias in Epidemiological Studies
Blinding
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One example of...
Cancer Survival Analysis
